Skip to main content

Table 6 Clinical characteristics of NAFLD patients and normal controls

From: Identifying potential biomarkers of nonalcoholic fatty liver disease via genome-wide analysis of copy number variation

Characteristics

Cases (%)

Controls (%)

Z

p value

ALT (IU/l)

27 (19–38)

19 (14–27)

− 7.91

< 0.001

AST (IU/l)

23 (20–28)

20 (18–24)

− 5.59

< 0.001

GLU (mmol/l)

5.34 (4.97–5.87)

5.19 (4.91–5.52)

− 3.34

0.001

TC (mmol/l)

5.09 (4.49–5.65)

5.03 (4.56–5.45)

− 0.94

0.35

TG (mmol/l)

1.77 (1.26–2.51)

1.18 (0.87–1.55)

− 9.50

< 0.001

HDL (mmol/l)

3.13 (2.53–3.75)

3.19 (2.687–3.56)

− 0.49

0.62

LDL (mmol/l)

1.21 (1.06–1.37)

1.35 (1.20–1.47)

− 6.70

< 0.001

  1. Bold indicates that the analysis result is statistically significant
  2. AST serum aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyltranspeptidase, FBG serum fasting glucose, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein, HDL-C high-density lipoprotein